Press Releases

Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), rang the Nasdaq Closing Bell on August 29, 2024 to recognize the Company’s recent progress and highlight upcoming milestones on its path to the U.S. market launch of its innovative patient-centric Genio® hypoglossal nerve stimulation technology for

London Children’s Hospital at London Health Sciences Centre (LHSC) and Shriners Hospitals for Children Canada (SHC Canada) have announced a unique affiliation agreement to enhance care, research and education. Patients and families in southwestern Ontario will now have access to specialized pediatric orthopedic care closer to home, as Shriners Hospital Canada continues to manage rare and complex cases while improving access. This affiliation also focuses on advancing pediatric research,

Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, “Median” or “The Company”) announces today that eyonis™ LCS, its proprietary Artificial Intelligence (AI)/machine learning (ML) powered Software as Medical Device (SaMD) for lung cancer screening (LCS), met the primary and all secondary endpoints in REALITY, the first of two pivotal studies required for marketing authorizations in U.S. and Europe. Median’s eyonis™ LCS SaMD is

Aclarion, a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today the expansion of the multi-center CLUE Trial to New Jersey. Justin Kubeck, MD, orthopedic spine surgeon and founder of Ocean Pain and Spine in Toms River, NJ will join an expanding network of spine surgeons participating in CLUE to build a growing body of data supporting the real-world

PolarisAR, a developer of advanced mixed-reality surgical guidance technology, today announces favorable data from two clinical abstracts evaluating its STELLAR Knee mixed-reality surgical guidance system for accuracy for total knee arthroplasty (TKA) and accuracy in a cadaveric simulated use study with four specimens, where left and right knees were used for surgery. The two studies will be podium presentations during the International Society for Technology in Arthroplasty’s

After more than 10 years of basic research, product and clinical development, the Medical Device Regulation (MDR) CE-mark is a crucial milestone and enables Augere Medical to start commercial launch in geographies accepting the MDR CE-mark. The basic research originated from clinical needs identified by leading Scandinavian clinicians and research organizations which laid the fundament for Augere's platform for AI assisted systems. David Borge Larsen, Augere's interim CEO, c

Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, through its Higi service, highlights its partnership with the American College of Cardiology (ACC) to introduce the Caring Hearts Initiative in Camden County, New Jersey. This initiative aims to bring essential supportive care services to communities with sig

Developing and manufacturing the Edison™ Histotripsy System Histosonics ( www.histosonics.com ) is pleased to announce that the University of Hong Kong has received a generous donation from the Li Ka Shing Foundation to install the first Histotripsy system in Asia. Founded by Mr. Li Ka Shing, the Foundation is a global philanthropic organization with a Hong Kong-focused focus that has provided more than HK$30 billion in funding for education, healthcare services, philanthropy and anti-p

Priority Health, a nationally recognized nonprofit health plan serving more than 1.3 million members, and Curai Health, a leading virtual care provider, have announced a new partnership to offer free virtual visits to Michigan residents 18 and older who are without health coverage – an estimated 400,000 people. The free virtual visits will be available through December 31, 2024. This new initiative seeks to address delayed care and poor health outcomes that can resul

Ibex Medical Analytics (Ibex), the leader in artificial intelligence (AI)-powered cancer diagnostics, today announced major advancements in customer growth, validation through a Quest Diagnostics study, regulatory approvals and expansion of its Board of Directors. Ibex exemplifies that AI-powered cancer diagnostics and digital pathology are not the future but the present, with pathologists using their cutting edge-technology and tools in routine practice around the world. The compan